NCT05083039View on ClinicalTrials.gov

Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19

CompletedOBSERVATIONAL

Enrollment

1,500

Participants

Timeline

Start Date

May 14, 2020

Primary Completion Date

December 14, 2020

Study Completion Date

September 3, 2021

Conditions

Coronavirus InfectionsVaccinePolio

Trial Locations (1)

610027

Federal State Budgetary Educational Institution of Higher Education Kirov State Medical University of the Ministry of Health of Russia, Kirov

All Listed Sponsors

lead

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products

OTHER_GOV

NCT05083039 - Observational Program, Study the Preventive Efficacy of the BiVac Polio Vaccine Against the Incidence of Acute Respiratory Infections, Including COVID-19 | Biotech Hunter | Biotech Hunter